Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Report a Problem to the Center for Biologics Evaluation & Research

Vaccine Adverse Events

                        
                Vaccine Adverse Event Reporting System (VAERS) Questions and Answers
          VAERS Overview Home
          Vaccines, Blood & Biologics
          Safety & Availability (Biologics)
          Report a Problem to the Center for Biologics Evaluation & Research
          Vaccine Adverse EventsReport a Problem to the Center for Biologics Evaluation & Research Vaccine Adverse Events
  	
        Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintImage
              glasses with magnified side effect on pill bottleThe Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program co-sponsored by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).

The purpose of VAERS is to detect possible signals of adverse events associated with vaccines. VAERS collects and analyzes information from reports of adverse events (possible side effects) that occur after the administration of US licensed vaccines.

Reports are welcome from all concerned individuals: patients, parents, health care providers, pharmacists and vaccine manufacturers.

General Information

VAERS Overview
	FDA's VAERS overview page
	Vaccine Adverse Event Reporting System Brochure
	Published by HHS, FDA and CDC
	Report a Vaccine Adverse Event
	Department of Health and Human Services
	Vaccine Adverse Event Reporting System (VAERS) Questions and Answers
	FDA's Questions and Answers
	Vaccine Adverse Event Reporting System (VAERS) Database Information
	Basic information about data collection
	Información en español acerca del Sistema para Reportar Reacciones Adversas a las Vacunas (VAERS)
	VAERS information in Spanish
	Understanding the Vaccine Adverse Event Reporting System (VAERS)
	Regulatory Submissions in Electronic Format for CBER-Regulated ProductsGuidances & Rules

Vaccine Adverse Event Reporting; Revised Form VAERS-2; Withdrawal of Proposed Revised Form (Federal Register) - April 21, 2006
	Vaccine Adverse Event Reporting System; Revised Form VAERS-2; Availability
	Guidance for Industry: How to Complete the Vaccine Adverse Event Reporting System Form (VAERS-1)Related Information

Dear Colleague Letter - Use of Haemophilus influenzae Conjugate Vaccines in Combination With DTaP in Infants - ARCHIVED
	DTaP/Hib have not been licensed for combination use in the primary immunization series in infantsSub-Topic Paragraphs
          Follow CBER
		Division of Communication and Consumer Affairs
			Office of Communication, Outreach and Development
			Center for Biologics Evaluation and Research
			Food and Drug Administration
			10903 New Hampshire Ave WO71-3103
			Silver Spring, MD 20993-0002
		
		ocod@fda.hhs.gov
		
		(800) 835-4709
			(240) 402-8010
		
		For Updates on Twitter, follow @fdacber
	Resources for You (Biologics)
			About the Center for Biologics Evaluation and Research (CBER)
			Report a Problem to the Center for Biologics Evaluation & Research
			Recalls (Biologics)
			CBER-Regulated Products: Shortages and Discontinuations
			Biologics Products & Establishments

                                                                                  Content current as of:
      01/27/2021
                  
                   
Regulated Product(s)
		 Biologics
			  			     			  						              
			
			 
			  VaccinesTopic(s)
			  Adverse Event ReportingVaccine Adverse Events                
                          

                        Vaccine Adverse Event Reporting System (VAERS) Questions and Answers
          VAERS Overview
 Subscribe for CBER Updates
                        Get e-mail updates on What’s New at CBER!
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop